- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03995095
Intervention in Spirituality at the End of Life. The Kibo Protocol
This work aims to study the benefits that the therapeutic interview Kibo in palliative care patients can have for spirituality.
A parallel randomized controlled trial of two groups was performed. Information was collected on 60 palliative care patients during the moments before and after the intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Valencia, Spain, 46010
- Universitat de València
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- To be 18 or more years of age.
- Being in advanced or terminal disease phase (following World Health Organization criteria).
- To have preserved cognitive capacity.
- To have signed the informed consent.
Exclusion Criteria:
a) Estimated time of survival: Patients with a life expectancy of two weeks or less will not be intervened.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Group of participants that received usual psychological attention.
|
|
Experimental: Experimental group
Group of participants that received usual psychological attention plus attention of spiritual needs following the Kibo protocol (intervention).
|
The kibo protocol is a therapeutic interview designed to address the spiritual needs of patients at the end of life.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the dimension of spirituality (PRE and POST measures)
Time Frame: Baseline up to 4 weeks
|
This variable was assessed with the Spirituality questionnaire from the Spanish Society of Palliative Care (SECPAL). This questionnaire contains 8 items, and it provides scores from 0 to 32, where higher values represent a better outcome. In order to observe the change in the dimension of spirituality, it was measured at in two time points: First measurement: PRE. Once the participant had signed the informed consent, the initial score for this outcome was assessed. Second measurement: POST. Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out. Between first and second measurement, the control group received the usual psychological attention, whereas the intervention group received usual psychological attention plus attention of spiritual needs following the Kibo protocol (intervention). |
Baseline up to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in resilience (PRE and POST measures)
Time Frame: Baseline up to 4 weeks
|
This variable was assessed with the Brief Resilient Coping Scale (BRCS). This scale contains 4 items, and it provides scores from 4 to 20, where higher values represent a better outcome. In order to observe the change in the dimension of resilience, it was measured at in two time points: First measurement: PRE. Once the participant had signed the informed consent, the initial score for this outcome was assessed. Second measurement: POST. Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out. Between first and second measurement, the control group received the usual psychological attention, whereas the intervention group received usual psychological attention plus attention of spiritual needs following the Kibo protocol (intervention). |
Baseline up to 4 weeks
|
Change in demoralization (PRE and POST measures)
Time Frame: Baseline up to 4 weeks
|
This variable was assessed with the Short Demoralization Scale (SDS). This scale contains 5 items, and it provides scores from 0 to 20, where lower values represent a better outcome. In order to observe the change in the dimension of demoralization, it was measured at in two time points: First measurement: PRE. Once the participant had signed the informed consent, the initial score for this outcome was assessed. Second measurement: POST. Up to 4 weeks after the first measurement, the second measurement of the same variable was carried out. Between first and second measurement, the control group received the usual psychological attention, whereas the intervention group received usual psychological attention plus attention of spiritual needs following the Kibo protocol (intervention). |
Baseline up to 4 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Pilar Barreto Martin, PhD, Universitat de València
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H1447334931417
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Palliative Care
-
Azienda Usl di BolognaIRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPalliative Care | Palliative Medicine | Hospice and Palliative Care NursingItaly
-
Mayo ClinicCompletedPalliative Care | Transitional CareUnited States
-
University of NottinghamCompletedPalliative Care | Long-Term CareUnited Kingdom
-
Ankara Yildirim Beyazıt UniversityRecruiting
-
University Hospital, CaenRecruitingPalliative CareFrance
-
University of PennsylvaniaNational Institute on Aging (NIA)Enrolling by invitationPalliative CareUnited States
-
Technische Universität DresdenUniversity Hospital DresdenCompletedPalliative CareGermany
-
Bispebjerg HospitalOdense University Hospital; Rigshospitalet, Denmark; Danish Cancer Society; Nordsjaellands... and other collaboratorsCompletedPalliative CareDenmark
-
University of GuadalajaraCompleted
Clinical Trials on Therapeutic interview: kibo protocol
-
Arkansas Children's Hospital Research InstituteEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedSIRS (Systemic Inflammatory Response Syndrome(United States
-
Mark A. LumleyCompleted
-
University Hospital, GenevaBayer; AstraZeneca; Vifor Pharma; Labatec Pharma SATerminatedMedication Adherence | Knowledge, Attitudes, Practice | Heart Failure With Reduced Ejection Fraction | Pharmacist-Patient Relations | Heart Failure; With DecompensationSwitzerland
-
Kyle KnightCompleted
-
Universidad Catolica de TemucoUnknown
-
Hospital de Santa Maria, PortugalInstituto Politécnico de LeiriaCompleted
-
Azienda Unità Sanitaria Locale Reggio EmiliaCompletedPancreatic Ductal AdenocarcinomaItaly
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Neuromed IRCCSRecruiting
-
Instituto Mexicano del Seguro SocialNot yet recruitingAppendicitis | Children, Only | Enhanced Recovery After Surgery